Compare Cadila Healthcare with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ORCHID PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ORCHID PHARMA CADILA HEALTHCARE/
ORCHID PHARMA
 
P/E (TTM) x 25.3 -87.8 - View Chart
P/BV x 4.4 25.2 17.6% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 CADILA HEALTHCARE   ORCHID PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
ORCHID PHARMA
Sep-13
CADILA HEALTHCARE/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs352194 181.6%   
Low Rs20735 590.0%   
Sales per share (Unadj.) Rs139.2276.5 50.4%  
Earnings per share (Unadj.) Rs11.8-79.2 -14.9%  
Cash flow per share (Unadj.) Rs18.6-43.5 -42.7%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs101.453.9 187.9%  
Shares outstanding (eoy) m1,023.7470.45 1,453.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.00.4 484.6%   
Avg P/E ratio x23.7-1.4 -1,642.9%  
P/CF ratio (eoy) x15.0-2.6 -571.0%  
Price / Book Value ratio x2.82.1 129.9%  
Dividend payout %29.80-   
Avg Mkt Cap Rs m286,0338,067 3,545.9%   
No. of employees `00013.42.8 478.8%   
Total wages/salary Rs m24,1452,527 955.5%   
Avg. sales/employee Rs Th10,632.76,956.1 152.9%   
Avg. wages/employee Rs Th1,801.2902.5 199.6%   
Avg. net profit/employee Rs Th898.5-1,993.0 -45.1%   
INCOME DATA
Net Sales Rs m142,53119,477 731.8%  
Other income Rs m1,139407 279.7%   
Total revenues Rs m143,67019,884 722.5%   
Gross profit Rs m24,1981,103 2,194.6%  
Depreciation Rs m6,9652,519 276.5%   
Interest Rs m3,4185,227 65.4%   
Profit before tax Rs m14,954-6,236 -239.8%   
Minority Interest Rs m28820 1,461.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m3,198-125 -2,554.3%   
Profit after tax Rs m12,044-5,580 -215.8%  
Gross profit margin %17.05.7 299.9%  
Effective tax rate %21.42.0 1,065.2%   
Net profit margin %8.5-28.7 -29.5%  
BALANCE SHEET DATA
Current assets Rs m87,15411,014 791.3%   
Current liabilities Rs m82,69432,060 257.9%   
Net working cap to sales %3.1-108.1 -2.9%  
Current ratio x1.10.3 306.8%  
Inventory Days Days7195 75.3%  
Debtors Days Days9434 279.6%  
Net fixed assets Rs m133,23629,440 452.6%   
Share capital Rs m1,024705 145.4%   
"Free" reserves Rs m102,7332,043 5,029.5%   
Net worth Rs m103,7573,800 2,730.5%   
Long term debt Rs m32,1469,018 356.5%   
Total assets Rs m236,86646,510 509.3%  
Interest coverage x5.4-0.2 -2,783.3%   
Debt to equity ratio x0.32.4 13.1%  
Sales to assets ratio x0.60.4 143.7%   
Return on assets %6.5-0.8 -858.9%  
Return on equity %11.6-146.9 -7.9%  
Return on capital %13.7-3.7 -367.6%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m52,7527,513 702.1%   
Fx outflow Rs m14,5045,649 256.8%   
Net fx Rs m38,2481,865 2,051.4%   
CASH FLOW
From Operations Rs m25,0541,682 1,489.8%  
From Investments Rs m-10,123-9,860 102.7%  
From Financial Activity Rs m-10,9426,644 -164.7%  
Net Cashflow Rs m3,989-1,535 -259.9%  

Share Holding

Indian Promoters % 74.8 32.3 231.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 4.6 180.4%  
FIIs % 5.9 3.3 178.8%  
ADR/GDR % 0.0 4.6 -  
Free float % 11.0 55.3 19.9%  
Shareholders   44,069 84,811 52.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SUVEN LIFE SCIENCES  PIRAMAL ENTERPRISES  JUBILANT PHARMOVA   NEULAND LABS  IPCA LABS  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tumbles 600 Points Tracking Global Selloff; HDFC & Tata Steel Top Losers(09:30 am)

A fresh spike in US bond yields and a firm dollar triggered a selloff in Asian share markets today.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 4, 2021 12:18 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - ALEMBIC PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS